145 related articles for article (PubMed ID: 25775871)
21. Long-term outcome for children born after a first-trimester measurement of increased nuchal translucency with a normal karyotype: a retrospective analysis.
Axt-Fliedner R; Hartge D; Chiriac A; Krapp M; Berg C; Geipel A; Germer U; Gembruch U
Ultraschall Med; 2009 Dec; 30(6):558-63. PubMed ID: 19137496
[TBL] [Abstract][Full Text] [Related]
22. Isolated Increased Nuchal Translucency in First Trimester Ultrasound Scan: Diagnostic Yield of Prenatal Microarray and Outcome of Pregnancy.
Stuurman KE; van der Mespel-Brouwer MH; Engels MAJ; Elting MW; Bhola SL; Meijers-Heijboer H
Front Med (Lausanne); 2021; 8():737936. PubMed ID: 34733861
[No Abstract] [Full Text] [Related]
23. [Perinatal and pediatric follow up of children with increased nuchal translucency and normal karyotype].
Vieira LA; Silva SV; de Faria RB; Lippi UG; Lopes RG
Rev Bras Ginecol Obstet; 2013 Jun; 35(6):274-80. PubMed ID: 23929201
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy outcome and long-term follow-up of fetuses with isolated increased NT: a retrospective cohort study.
Iuculano A; Pagani G; Stagnati V; Floris M; Ibba RM; Monni G
J Perinat Med; 2016 Mar; 44(2):237-42. PubMed ID: 26352075
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype.
Senat MV; De Keersmaecker B; Audibert F; Montcharmont G; Frydman R; Ville Y
Prenat Diagn; 2002 May; 22(5):345-9. PubMed ID: 12001183
[TBL] [Abstract][Full Text] [Related]
26. Increased nuchal translucency with normal karyotype and genomic microarray analysis: A multicenter observational study.
Spataro E; Cordisco A; Luchi C; Filardi GR; Masini G; Pasquini L
Int J Gynaecol Obstet; 2023 Jun; 161(3):1040-1045. PubMed ID: 36572018
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening.
Äyräs O; Eronen M; Tikkanen M; Rahkola-Soisalo P; Paavonen J; Stefanovic V
Acta Obstet Gynecol Scand; 2016 May; 95(5):541-6. PubMed ID: 26918672
[TBL] [Abstract][Full Text] [Related]
28. Disappearance of enlarged nuchal translucency before 14 weeks' gestation: relationship with chromosomal abnormalities and pregnancy outcome.
Müller MA; Pajkrt E; Bleker OP; Bonsel GJ; Bilardo CM
Ultrasound Obstet Gynecol; 2004 Aug; 24(2):169-74. PubMed ID: 15287055
[TBL] [Abstract][Full Text] [Related]
29. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency.
Timmerman E; Pajkrt E; Bilardo CM
Ultrasound Obstet Gynecol; 2009 Oct; 34(4):373-8. PubMed ID: 19618399
[TBL] [Abstract][Full Text] [Related]
30. Increased nuchal translucency in fetuses with a normal karyotype-diagnosis and management: An observational study.
Socolov D; Socolov R; Gorduza VE; Butureanu T; Stanculescu R; Carauleanu A; Pavaleanu I
Medicine (Baltimore); 2017 Jul; 96(29):e7521. PubMed ID: 28723764
[TBL] [Abstract][Full Text] [Related]
31. Pregnancy outcome of euploid fetuses with increased nuchal translucency: how bad is the news?
Maymon R; Weinraub Z; Herman A
J Perinat Med; 2005; 33(3):191-8. PubMed ID: 15914340
[TBL] [Abstract][Full Text] [Related]
32. Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype.
Yang X; Li R; Fu F; Zhang Y; Li D; Liao C
J Matern Fetal Neonatal Med; 2017 Jan; 30(2):194-198. PubMed ID: 26998667
[TBL] [Abstract][Full Text] [Related]
33. The prognosis of fetuses with transient nuchal translucency in the first and early second trimester.
Fukada Y; Yasumizu T; Takizawa M; Amemiya A; Hoshi K
Acta Obstet Gynecol Scand; 1997 Nov; 76(10):913-6. PubMed ID: 9435728
[TBL] [Abstract][Full Text] [Related]
34. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis.
Grande M; Jansen FA; Blumenfeld YJ; Fisher A; Odibo AO; Haak MC; Borrell A
Ultrasound Obstet Gynecol; 2015 Dec; 46(6):650-8. PubMed ID: 25900824
[TBL] [Abstract][Full Text] [Related]
35. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
[TBL] [Abstract][Full Text] [Related]
36. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
37. The added value of detailed early anomaly scan in fetuses with increased nuchal translucency.
Zalel Y; Zemet R; Kivilevitch Z
Prenat Diagn; 2017 Mar; 37(3):235-243. PubMed ID: 28010037
[TBL] [Abstract][Full Text] [Related]
38. The performance of an intermediate 16th-week ultrasound scan for the follow-up of euploid fetuses with increased nuchal translucency.
Le Lous M; Bouhanna P; Colmant C; Rozenberg P; Quibel T
Prenat Diagn; 2016 Feb; 36(2):148-53. PubMed ID: 26661276
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy outcome in foetuses with increased nuchal translucency - 10-years' experience in a prenatal medical practice.
Tekesin I
J Obstet Gynaecol; 2020 May; 40(4):455-460. PubMed ID: 31416379
[TBL] [Abstract][Full Text] [Related]
40. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
Yang Y; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
